Skip to main content
Premium Trial:

Request an Annual Quote

VC Firm Summit to Buy Minority Stake in Genomic Tool Shop Fermentas

NEW YORK (GenomeWeb News) — Venture capital group Summit Partners plans to make “a significant minority investment” in genomics and proteomics technology provider Fermentas International, the company said today.
Fermentas did not disclose the amount of the investment -- it said it “signed a definitive agreement to accept” Summit’s offer -- but said it plans to use the funds for organic growth and for new partnerships and acquisitions.
Fermentas was founded in the mid-1970s as part of the Soviet Union-funded Institute of Applied Enzymology and became an independent entity in 1995.
Although the company retains its offices in Vilnius, Lithuania, it is headquartered in Burlington, Ontario.
As part of the investment, Thomas Jennings, a principal with Summit Partners, will join the Fermentas board.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.